Rabe, Baby Boy .
HRN: 29-32-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/16/2026
07/23/2026
IV
33mg
Q24h
PSNB; T/c Neonatal Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes